The Weight of Deception: A Warning for Big Pharma The pharmaceutical industry's reputation has long been marred by allegations that profits are prioritized over patient welfare.
A recent federal judge's ruling in a lawsuit against Novo Nordisk sheds light on a disturbing pattern: companies may use their marketing muscle to mislead investors about new treatments' efficacy and safety.
At the center of this controversy is CagriSema, an experimental weekly injection designed to combat obesity.